Zura Bio
ZURA | NASDAQ
$1.08
-$0.16 (-12.90%)
At close: Nov 16, 2026, 4:00 PM ET
$1.08
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-12.90%
(1D)No price chart data available for 1D timeframe.
Rating
23
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #968/1021 (Top 95%)
Key Statistics
Market Data
Market Cap $137.93M
1D Range
1.05 1.23
52W Range
1.05 7.04
Valuation (TTM)
PE -0.96
PB 0.78
EV/EBITDA 0.52
Valuation (NTM)
Forward PE N/A
Forward PEG -0.26
Price Target $20.00
Cash Flow
FCF Yield -59.2%
SBC Adj. FCF Yield -71.8%
SBC Impact -21.3%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y -28.9% |
2.6%
FCF 3Y | 5Y -51.4% |
N/A
Returns
ROA -48.0%
ROE -54.0%
ROIC -56.6%
Financial Health
Net Cash
$187.65M
Current Ratio 11.29
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its ke...
Sector Healthcare
Industry Biotechnology
Employees 40
IPO Date Mar 21, 2023
Website zurabio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$20.00
Upside
+1751.85%
Buy (4)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ZURA